Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.4M Buy
510,056
+201,284
+65% +$23.2M 0.22% 62
2025
Q4
$32.5M Sell
308,772
-560,550
-64% -$52.6M 0.12% 124
2025
Q3
$73M Buy
869,322
+268,394
+45% +$22.1M 0.34% 48
2025
Q2
$47.6M Sell
600,928
-852,150
-59% -$67.7M 0.21% 66
2025
Q1
$130M Buy
1,453,078
+1,103,453
+316% +$103M 0.71% 21
2024
Q4
$34.8M Buy
349,625
+32,845
+10% +$3.39M 0.21% 87
2024
Q3
$36M Sell
316,780
-78,745
-20% -$9.36M 0.2% 86
2024
Q2
$49M Sell
395,525
-904,577
-70% -$117M 0.28% 61
2024
Q1
$172M Sell
1,300,102
-617,897
-32% -$76.2M 0.89% 22
2023
Q4
$209M Buy
1,917,999
+1,034,806
+117% +$107M 1.52% 9
2023
Q3
$90.9M Buy
883,193
+392,860
+80% +$42.3M 0.7% 22
2023
Q2
$56.6M Sell
490,333
-188,794
-28% -$21.4M 0.46% 41
2023
Q1
$72.3M Sell
679,127
-291,077
-30% -$31.4M 0.65% 25
2022
Q4
$108M Sell
970,204
-2,216,448
-70% -$227M 0.6% 39
2022
Q3
$275M Buy
3,186,652
+2,815,455
+758% +$251M 1.29% 8
2022
Q2
$33.9M Sell
371,197
-1,824,790
-83% -$162M 0.12% 107
2022
Q1
$180M Buy
2,195,987
+1,564,187
+248% +$123M 0.63% 21
2021
Q4
$48.4M Sell
631,800
-1,309,825
-67% -$104M 0.17% 108
2021
Q3
$146M Sell
1,941,625
-268,753
-12% -$20.4M 0.5% 25
2021
Q2
$172M Buy
2,210,378
+512,132
+30% +$38.1M 0.75% 23
2021
Q1
$125M Sell
1,698,246
-773,274
-31% -$57M 0.41% 45
2020
Q4
$193M Buy
2,471,520
+1,621,399
+191% +$124M 0.7% 21
2020
Q3
$67.3M Buy
850,121
+738,856
+664% +$57.9M 0.5% 52
2020
Q2
$8.21M Sell
111,265
-2,390,705
-96% -$180M 0.06% 218
2020
Q1
$181M Buy
2,501,970
+1,901,729
+317% +$149M 1.42% 7
2019
Q4
$52.1M Sell
600,241
-584,888
-49% -$48M 0.32% 86
2019
Q3
$95.2M Sell
1,185,129
-793,077
-40% -$63.6M 0.61% 29
2019
Q2
$158M Buy
+1,978,206
New +$151M 1.22% 12
2018
Q4
Sell
-2,452,538
Closed -$166M 777
2018
Q3
$166M Buy
2,452,538
+1,000,076
+69% +$63.7M 0.96% 21
2018
Q2
$84.1M Sell
1,452,462
-1,734,357
-54% -$97.8M 0.45% 56
2018
Q1
$166M Buy
3,186,819
+2,397,539
+304% +$129M 1.02% 17
2017
Q4
$42.4M Buy
789,280
+24,492
+3% +$1.36M 0.33% 82
2017
Q3
$46.7M Buy
+764,788
New +$46.4M 0.43% 65
2017
Q2
Sell
-904,214
Closed -$54.8M 928
2017
Q1
$54.8M Buy
904,214
+586,752
+185% +$35.6M 0.68% 39
2016
Q4
$17.8M Sell
317,462
-904,021
-74% -$52.9M 0.18% 141
2016
Q3
$72.7M Buy
1,221,483
+1,216,009
+22,214% +$71.1M 0.84% 33
2016
Q2
$301K Buy
+5,474
New +$291K 0.01% 362
2016
Q1
Sell
-229,214
Closed -$11.6M 349
2015
Q4
$11.6M Sell
229,214
-912,229
-80% -$46M 0.19% 73
2015
Q3
$53.8M Sell
1,141,443
-44,554
-4% -$2.37M 1.12% 21
2015
Q2
$64.4M Buy
1,185,997
+596,275
+101% +$33.4M 0.87% 23
2015
Q1
$32.3M Buy
589,722
+409,458
+227% +$23.2M 0.44% 41
2014
Q4
$9.77M Sell
180,264
-92,286
-34% -$5.14M 0.13% 94
2014
Q3
$15.4M Sell
272,550
-947,628
-78% -$53.2M 0.24% 80
2014
Q2
$67.4M Buy
1,220,178
+416,026
+52% +$22.7M 0.81% 26
2014
Q1
$43.6M Buy
804,152
+489,154
+155% +$25.3M 0.57% 44
2013
Q4
$15M Sell
314,998
-99,702
-24% -$4.56M 0.13% 136
2013
Q3
$18.8M Buy
414,700
+406,280
+4,825% +$18.5M 0.2% 120
2013
Q2
$374K Buy
+8,420
New +$376K 0.01% 339

Other funds holding MRK

Natixis's MRK Position: Q1 2026 in Review

Natixis increased its Merck (MRK) stake by 65% in Q1 2026, buying an estimated $23.2M and bringing the position to 510,056 shares worth $61.4M. The position accounts for 0.22% of the portfolio, ranked #62.

Natixis first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. The position peaked at $275M in Q3 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Natixis held 510,056 shares of Merck worth $61.4M as of Q1 2026.
  • Natixis bought 201,284 Merck shares in Q1 2026, an estimated $23.2M.
  • Merck made up 0.22% of Natixis's portfolio in Q1 2026, its #62 holding.
  • Natixis first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
  • Natixis's Merck position peaked at $275M in Q3 2022.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.